Arkas Pharma Pvt Ltd
Glimepiride (1mg) + Metformin (000mg)
Endoglim M1 Tablet PR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet PR
Endoglim M1 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Use it as advised by your doctor or check the label for directions before use. Endoglim M1 Tablet PR is to be taken with food.
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
It is unsafe to consume alcohol with Endoglim M1 Tablet PR.
Endoglim M1 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Endoglim M1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Endoglim M1 Tablet PR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Monitor your blood sugar level regularly while you are taking this medicine. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Endoglim M1 Tablet PR may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
To ensure the effectiveness and safety of Endoglim M1 Tablet PR, it is essential to store this medicine in its original container or pack, tightly closed. Please follow the instructions provided on the packaging or label for proper storage. Dispose of any unused medication responsibly.
Yes, using Endoglim M1 Tablet PR may increase the risk of lactic acidosis, a rare but serious medical condition caused by elevated levels of lactic acid in the blood. This is more likely to occur in individuals with pre-existing kidney disease, older adults, or those who consume excessive amounts of alcohol. If you experience symptoms such as muscle weakness, dizziness, tiredness, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate, seek immediate medical attention and discontinue use.
Endoglim M1 Tablet PR is a combination medication consisting of Glimepiride and Metformin. It is prescribed to manage type 2 diabetes mellitus (DM) in adults, helping regulate blood sugar levels when taken alongside a balanced diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while Metformin reduces glucose production in the liver and enhances insulin sensitivity.
Common side effects associated with the use of Endoglim M1 Tablet PR may include hypoglycemia (low blood sugar), altered taste, nausea, stomach discomfort, diarrhea, and headaches. Rare but serious side effects can occur, such as lactic acidosis. Long-term use may also lead to Vitamin B12 deficiency, potentially causing anemia, nerve problems, tingling sensation in hands and feet, weakness, urinary issues, changes in mental status, and balance difficulties.
Yes, prolonged use of Endoglim M1 Tablet PR may cause Vitamin B12 deficiency due to interference with its absorption in the stomach. Untreated, this can lead to anemia and nerve problems, including tingling sensations in hands and feet, weakness, urinary issues, changes in mental status, and balance difficulties. To prevent these complications, regular intake of external Vitamin B12 sources is recommended.
Yes, using Endoglim M1 Tablet PR can result in hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. These symptoms are more likely to occur when skipping or delaying meals, consuming alcohol, over-exercising, or taking other antidiabetic medications alongside Endoglim M1 Tablet PR.
No, consuming alcohol while using Endoglim M1 Tablet PR is not recommended. Alcohol can lower blood sugar levels and increase the risk of lactic acidosis.